Scholarlink

Background <p>Pulmonary injury in sepsis often develops into acute respiratory distress syndrome (ARDS), in which the polarization state of alveolar macrophages (AMs) is a central pathogenic factor. Bone marrow mesenchymal stem cell-derived exosomes (BMSCs-exo) have demonstrated therapeutic potential in septic ARDS through metabolic modulation, yet the specific mechanisms remain unclear. This study investigated whether BMSCs-exo attenuate ARDS by regulating AM polarization via glycolysis inhibition and clarified the role of HOXA9.</p> Methods <p>BMSCs were identified using flow cytometry and trilineage differentiation. BMSCs-exo were characterized by transmission electron microscopy, nanoparticle tracking analysis and Western blot. An in vitro septic model was established by stimulating MH-S cells with lipopolysaccharide (LPS, 1&#xa0;µg/mL). In vivo, ARDS was induced in C57BL/6 mice using either LPS (10&#xa0;mg/kg) or cecal ligation and puncture (CLP), followed by caudal vein injection of BMSCs-exo. Glycolysis and macrophage polarization were evaluated with Western blot, RT-qPCR, and immunofluorescence.</p> Results <p>BMSCs-exo treatment improved survival in septic mice, alleviated pulmonary inflammation and edema, suppressed glycolysis in AMs, and restored M1/M2 balance. In vitro, BMSCs-exo downregulated glycolysis-associated markers in LPS-stimulated MH-S cells, suppressed M1 polarization, and facilitated M2 polarization. Notably, knockdown of the HOXA9 gene significantly diminished the ability of BMSCs-exo to suppress glycolysis and M1 polarization in MH-S cells.</p> Conclusion <p>BMSCs-exo mitigate sepsis-induced ARDS by inhibiting HOXA9-mediated glycolysis and re-establishing AM polarization homeostasis, supporting their potential as a promising therapeutic approach for ARDS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exosomes derived from bone marrow mesenchymal stem cells alleviate sepsis-induced ARDS via inhibition of HOXA9-mediated glycolysis in alveolar macrophages

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月18日

查看全文
  • Song Hu,
  • Yu Wang,
  • Wenyu Zhou,
  • Lina Zhu,
  • Yuanli Chen,
  • Quanfu Li,
  • Xin Lv,
  • Hao Yang

摘要

Background

Pulmonary injury in sepsis often develops into acute respiratory distress syndrome (ARDS), in which the polarization state of alveolar macrophages (AMs) is a central pathogenic factor. Bone marrow mesenchymal stem cell-derived exosomes (BMSCs-exo) have demonstrated therapeutic potential in septic ARDS through metabolic modulation, yet the specific mechanisms remain unclear. This study investigated whether BMSCs-exo attenuate ARDS by regulating AM polarization via glycolysis inhibition and clarified the role of HOXA9.

Methods

BMSCs were identified using flow cytometry and trilineage differentiation. BMSCs-exo were characterized by transmission electron microscopy, nanoparticle tracking analysis and Western blot. An in vitro septic model was established by stimulating MH-S cells with lipopolysaccharide (LPS, 1 µg/mL). In vivo, ARDS was induced in C57BL/6 mice using either LPS (10 mg/kg) or cecal ligation and puncture (CLP), followed by caudal vein injection of BMSCs-exo. Glycolysis and macrophage polarization were evaluated with Western blot, RT-qPCR, and immunofluorescence.

Results

BMSCs-exo treatment improved survival in septic mice, alleviated pulmonary inflammation and edema, suppressed glycolysis in AMs, and restored M1/M2 balance. In vitro, BMSCs-exo downregulated glycolysis-associated markers in LPS-stimulated MH-S cells, suppressed M1 polarization, and facilitated M2 polarization. Notably, knockdown of the HOXA9 gene significantly diminished the ability of BMSCs-exo to suppress glycolysis and M1 polarization in MH-S cells.

Conclusion

BMSCs-exo mitigate sepsis-induced ARDS by inhibiting HOXA9-mediated glycolysis and re-establishing AM polarization homeostasis, supporting their potential as a promising therapeutic approach for ARDS.